SCHEMBL25867458

SCHEMBL25867458

Fc1cc(CNc2nc(Cl)nc3ccccc23)ccc1Cl

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 8/20 0.68
PDE5A O76074 4/20 0.68
USP1 O94782 2/20 0.54
WDR48 Q8TAF3 2/20 0.54
MAPT P10636 3/20 0.51
KMT2A Q03164 3/20 0.51
LMNA P02545 2/20 0.51
MEN1 O00255 2/20 0.51
POLB P06746 1/20 0.50
MAPK1 P28482 1/20 0.50
CCNE2 O96020 2/20 0.49
CCNE1 P24864 2/20 0.49
CDK2 P24941 2/20 0.49
RAD52 P43351 1/20 0.49
KDM4E B2RXH2 1/20 0.48
ALDH1A1 P00352 1/20 0.48
PKM P14618 1/20 0.48
UBE2N P61088 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
RCE1 Q9Y256 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13929497 0.91 APP (0.70) APPPDE5AUSP1WDR48MAPT
SCHEMBL25306105 0.88 APP (0.74) APPPDE5AUSP1WDR48MAPT
SCHEMBL3782735 0.84 APP (0.81) APPPDE5AUSP1WDR48MAPT
SCHEMBL3113122 0.82 APP (1.00) APPPDE5AMAPTKMT2ALMNA
SCHEMBL29388255 0.82 APP (1.00) APPPDE5AMAPTKMT2ALMNA
SCHEMBL3106597 0.81 APP (0.85) APPPDE5AUSP1WDR48MAPT
SCHEMBL25867456 0.79 APP (0.62) APPPDE5AMAPTKMT2ALMNA
SCHEMBL3113251 0.79 APP (0.81) APPPDE5AMAPTKMT2ALMNA
SCHEMBL3121152 0.79 APP (0.81) APPPDE5AMAPTKMT2ALMNA
SCHEMBL3638414 0.78 APP (0.74) APPPDE5AUSP1WDR48MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023133221-A2 SMARCA2/4 INHIBITION AS A STRATEGY TO TREAT TUMORS THAT HARBOR ABERRANT BAF ASSEMBLIES BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2023-07-13 WO disclosed